- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Frazier Life Sciences Appoints New Senior Advisor
Christian Schade joins the biotech investment firm in advisory role.
Apr. 6, 2026 at 1:32pm
Got story updates? Submit your updates here. ›
Frazier Life Sciences, a prominent venture capital firm focused on the life sciences industry, has announced the appointment of Christian Schade as a new Senior Advisor. Schade brings extensive experience in the biotech and pharmaceutical sectors to the firm, having previously held executive roles at several leading companies.
Why it matters
Frazier Life Sciences is a major player in funding and supporting innovative biotech startups. Schade's addition to the firm's advisory team is seen as a strategic move to bolster its expertise and industry connections as it continues to identify promising investment opportunities in the rapidly evolving life sciences landscape.
The details
In his new role, Schade will provide strategic counsel and guidance to the Frazier Life Sciences team as they evaluate potential investments and support their portfolio companies. Schade's background includes serving as the CEO of Aprea Therapeutics, a clinical-stage biopharmaceutical company, as well as executive positions at Novartis and Bristol Myers Squibb.
- Frazier Life Sciences announced Schade's appointment on April 6, 2026.
The players
Frazier Life Sciences
A prominent venture capital firm focused on investing in the life sciences industry.
Christian Schade
An experienced biotech and pharmaceutical executive who has been appointed as a Senior Advisor at Frazier Life Sciences.
What they’re saying
“Christian's deep expertise in the life sciences industry and his track record of success will be invaluable as we continue to identify and support the most promising innovations in this dynamic sector.”
— James Tobin, Managing Partner, Frazier Life Sciences
The takeaway
Frazier Life Sciences' appointment of Christian Schade as a Senior Advisor underscores the firm's commitment to strengthening its industry knowledge and network as it seeks to capitalize on emerging opportunities in the rapidly evolving life sciences landscape.
